TheJakartaPost
Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.
People rush for red ginger supplements as virus fears grow
Stamina booster: A woman sorts dried ginger, which is the main ingredient for a traditional herbal drink, in Rembun village, Nogosari district, Boyolali regency, Central Java, on March 7
Change Size
S
tamina booster: A woman sorts dried ginger, which is the main ingredient for a traditional herbal drink, in Rembun village, Nogosari district, Boyolali regency, Central Java, on March 7. The prices of dried herbs have jumped recently as they are believed to improve stamina and thus help stave off the coronavirus.(Antara/Aloysius Jarot Nugroho)
Demand for red ginger supplements has increased sharply, amid growing fears over the spread of the novel coronavirus in the country, as people believe the plant can boost the immune system, a senior executive of a pharmaceutical company has said.
Publicly listed Kalbe Farma has increased production of the herbal supplement made from red ginger extract by about 50 percent to meet the increase in demand for such supplements, the company’s president director Vidjongtius said.
“We have been developing herbal-based products and mostly use red ginger extract as the main ingredient. And it is such a coincidence that red ginger is in high demand at the moment,” Vidjongtius told a press briefing on Wednesday.
Red ginger is a plant that can be easily found in Indonesia. People believe it can help prevent the spread of the coronavirus as it can strengthen the body’s immune system. People also use it as a remedy for a cough or headache. Kalbe Farma had been selling a liquid herbal product made from red ginger long before the coronavirus outbreak.
Vidjongtius said that at the moment Kalbe Farma had between 400 and 500 tons of red ginger in its warehouses, enough to meet the surge in demand. The red ginger was obtained from about 9,000 farmers across Indonesia who had joined the farmer communities established by Kalbe, he said. The supply, he said, were enough not only for Kalbe Farma, but also for other producers.
Vidjongtius said Kalbe Farma‘s stocks for most of its pharmaceutical products were large enough to meet the demand for the next several months.
“We have enough supply for pharmaceutical products to last 10 to 11 months. The stocks comprise raw materials, half-made products and even stock in outlets,” he said.
Vidjongtius admitted that he initially worried that the COVID-19 outbreak would disrupt the supply of raw materials, as China is the main source of Kalbe Farma’s raw materials. In early February, producers of raw materials in China temporarily their production, but he said the halted disruption did not affect his company because of the large supply of raw material in its warehouses.
"We are now less worried because since according to the latest update, they [suppliers in China] have started to resume their production, although not at full capacity. They also started to resume [raw material] shipments,” he said.
However, although the shipment of raw materials from China would soon return to normal, Kalbe Farma is seeking other sources of raw materials to reduce its dependence on China such as India, Europe and the United States.
Indonesia’s pharmaceutical industry still greatly relies on imported raw materials. According to the national pharmaceutical industry‘s estimate, about 95 percent of its raw materials are imported, with a total value of US$2.5 billion a year. About 60 percent of the imported raw materials are shipped from China.
